Carmell (CTCX) Competitors $1.04 -0.12 (-10.54%) As of 09/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CTCX vs. PDEX, NSPR, OBIO, ZJYL, FONR, BDMD, EDAP, NTRB, APYX, and VANIShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include Pro-Dex (PDEX), InspireMD (NSPR), Orchestra BioMed (OBIO), Jin Medical International (ZJYL), Fonar (FONR), Baird Medical Investment (BDMD), EDAP TMS (EDAP), Nutriband (NTRB), Apyx Medical (APYX), and Vivani Medical (VANI). These companies are all part of the "medical equipment" industry. Carmell vs. Its Competitors Pro-Dex InspireMD Orchestra BioMed Jin Medical International Fonar Baird Medical Investment EDAP TMS Nutriband Apyx Medical Vivani Medical Pro-Dex (NASDAQ:PDEX) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation. Do institutionals & insiders believe in PDEX or CTCX? 15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by insiders. Comparatively, 29.0% of Carmell shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is PDEX or CTCX more profitable? Pro-Dex has a net margin of 13.48% compared to Carmell's net margin of 0.00%. Pro-Dex's return on equity of 26.67% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex13.48% 26.67% 14.95% Carmell N/A -217.50%-50.22% Which has more volatility and risk, PDEX or CTCX? Pro-Dex has a beta of -0.04, meaning that its share price is 104% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Do analysts prefer PDEX or CTCX? Pro-Dex currently has a consensus price target of $56.00, indicating a potential upside of 62.98%. Given Pro-Dex's stronger consensus rating and higher possible upside, research analysts clearly believe Pro-Dex is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings & valuation, PDEX or CTCX? Pro-Dex has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$66.59M1.68$8.98M$2.7012.73Carmell$32.84K662.05-$15.44MN/AN/A Does the media favor PDEX or CTCX? In the previous week, Pro-Dex had 2 more articles in the media than Carmell. MarketBeat recorded 2 mentions for Pro-Dex and 0 mentions for Carmell. Pro-Dex's average media sentiment score of 0.02 beat Carmell's score of 0.00 indicating that Pro-Dex is being referred to more favorably in the media. Company Overall Sentiment Pro-Dex Neutral Carmell Neutral SummaryPro-Dex beats Carmell on 11 of the 14 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.74M$78.64M$5.79B$10.40BDividend YieldN/AN/A5.63%4.60%P/E RatioN/A11.3976.4826.75Price / Sales662.0543.10531.72124.23Price / CashN/A18.4137.9261.55Price / Book0.9712.1213.726.40Net Income-$15.44M-$25.92M$3.29B$271.62M7 Day Performance-45.72%-4.78%2.66%3.46%1 Month Performance-59.69%2.50%6.02%9.87%1 Year Performance152.80%56.68%80.02%28.45% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmellN/A$1.04-10.5%N/A+166.7%$21.74M$32.84K0.0014PDEXPro-Dex2.5694 of 5 stars$33.81+3.6%$56.00+65.6%+24.4%$106.41M$66.59M12.52140NSPRInspireMD3.6279 of 5 stars$2.41+1.3%$4.50+86.7%-6.0%$100.55M$7.07M-3.2150Positive NewsOBIOOrchestra BioMed3.1041 of 5 stars$2.53-2.7%$13.50+433.6%-54.0%$100.47M$2.64M-1.384Short Interest ↑ZJYLJin Medical InternationalN/A$0.62-0.9%N/A-78.4%$98.08M$23.50M0.00245Positive NewsGap UpFONRFonar1.0958 of 5 stars$15.47-0.3%N/A-13.0%$96.22M$102.88M12.38480News CoverageUpcoming EarningsAnalyst DowngradeHigh Trading VolumeBDMDBaird Medical InvestmentN/A$2.66+2.3%N/AN/A$92.89MN/A0.00N/AEDAPEDAP TMS2.2794 of 5 stars$2.33-3.3%$8.50+264.8%-17.2%$90.11M$69.18M-3.82230NTRBNutriband2.9799 of 5 stars$7.15+6.1%$13.00+81.8%+28.9%$81.11M$2.14M-2.4910News CoverageAnalyst DowngradeShort Interest ↓APYXApyx Medical2.5781 of 5 stars$2.13flatN/A+110.1%$80.56M$48.10M-4.73270Positive NewsShort Interest ↓VANIVivani Medical3.4427 of 5 stars$1.21-4.7%$4.00+230.6%+14.6%$75.24MN/A-2.6920News CoveragePositive NewsInsider Trade Related Companies and Tools Related Companies PDEX Alternatives NSPR Alternatives OBIO Alternatives ZJYL Alternatives FONR Alternatives BDMD Alternatives EDAP Alternatives NTRB Alternatives APYX Alternatives VANI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTCX) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTCX Stock Alerts